Medtronic Buys Mazor Robotics For $1.3Bn

Medtronic is straightening up as a market leader in spinal surgery after agreeing to buy the shares of Mazor Robotics that it does not already own. The $1.3bn deal builds on an existing agreement between the companies formed in May 2016 and strengthens Medtronic as the front runner in the spine robotics field.

Mazor X(TM) Robotic Guidance System (Mazor X),
• Source: Mazor Robotics Ltd.

Medtronic PLC is cementing its position in surgical robotics by paying $1.3bn for the shares of Mazor Robotics Ltd. it does not already own, the companies announced Sept. 20.

Medtronic already owned 11% of the company and agreed to pay approximately $1.64bn, or $1.34bn net of Medtronic’s existing stake in Mazor and cash acquired, to own all of the...

More from Deals

More from Business

Edwards Lifesciences Holds 2025 EPS Outlook Despite Tariff Headwind

 
• By 

The brunt of the tariff exposure stems from Singapore and Costa Rica, which together account for an estimated 70% to 80% of the tariff-related cost burden. Less than 10% of the exposure is tied to China.

Data Finds Capillary Blood Is A Reliable Alternative To Venous Blood For Routine Testing

 

A study from Babson Diagnostics published in the peer-reviewed Journal of Applied Laboratory Medicine showed that capillary blood sample volume issues can overcome historical challenges, such as poor quality, through a technique called assay miniaturization.

Inclusive By Design: UK Invites Sponsors To Submit Trial Diversity Plans

 
• By 

The UK has issued clearer guidance to help drug and medical device sponsors demonstrate how they intend to include a diverse and relevant range of participants in their clinical trials.